Intuitive Surgical Stock Plummets 34.77% in Trading Volume Ranking 39th Despite FDA Clearance for Revolutionary SP SureForm 45 Stapler

On April 10, 2025, Intuitive Surgical (ISRG) experienced a significant decline, with its trading volume reaching $19.88 billion, a 34.77% decrease from the previous day, ranking 39th in the day's stock market activity. The company's stock price also dropped by 6.39%.

Intuitive Surgical has received FDA clearance for its SP SureForm 45 stapler, designed for single-port robotic surgeries. This stapler is the first of its kind to be approved for such procedures in the United States, enhancing surgical control and efficiency. The SP SureForm 45 stapler is equipped with SmartFire technology, which optimizes staple formation by continuously monitoring tissue. This innovation is expected to provide surgeons with more control during procedures, particularly in thoracic, colorectal, and urology surgeries. However, it is not cleared for transoral otolaryngology procedures.

This FDA clearance is a significant milestone for Intuitive Surgical, as it expands the capabilities of its da Vinci SP surgical system. The SP SureForm 45 stapler is fully wristed, allowing for greater precision and flexibility during minimally invasive surgeries. This advancement is likely to bolster investor confidence in the company's innovative technology and its potential to revolutionize the field of robotic surgery.